SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Statement On Deviation Or Variation In The Use Of Proceeds Of Preferential Issue
As per letter attached04-02-2022
04-02-2022
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E 04.02.2022
As per letter attached04-02-2022
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Outcome Of The Board Meeting Held Today I.E. 04.02.2022
As per letter attached04-02-2022
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
As per letter attached29-01-2022
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Board Meeting Intimation for For Consideration Of Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2021.
SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2022 ,inter alia, to consider and approve Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2021.27-01-2022
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
As per letter attached26-01-2022
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Shareholding for the Period Ended December 31, 2021
Sun Pharma Advanced Research Company Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here18-01-2022
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
As per letter attached12-01-2022
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- DINESH LAHOTIDesignation :- Company Secretary and Compliance Officer06-01-2022